Healthcare >> CEO Interviews >> October 16, 2000
REMI BARBIER, Pain Therapeutics, Inc.s Founder, serves as President,
CEO and Chairman of the company. Prior to PTI, Mr. Barbier helped in the
growth or founding of: Exelixis Inc., a functional genomics company;
ArQule, a chemistry company; and EnzyMed (now owned by Albany Molecular
Research), a chemistry company. Mr. Barbier served as Chief Operating
Officer of Exelixis. Prior to that, he was Vice President of Corporate
Development and Clinical Project Manager of Xoma Corporation, a
biotechnology company. Mr. Barbier received his BA from Oberlin College
and his MBA from the University of Chicago. Profile
Therapeutics, including its history, development, markets, and your view
of the firm's future potential?
Mr. Barbier: Pain
